Long Cast Advisers, an investment management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s cumulative net returns improved 4%. The fund returned a cumulative 266% net of fees, or 14% CAGR, since its inception in November 2015 through the quarter-end of Q3 2025. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.
In its third-quarter 2025 investor letter, Long Cast Advisers highlighted stocks such as Pro-Dex, Inc. (NASDAQ:PDEX). Pro-Dex, Inc. (NASDAQ:PDEX) is a leading powered surgical instruments manufacturing company for medical device original equipment manufacturers. The one-month return of Pro-Dex, Inc. (NASDAQ:PDEX) was 1.50%, and its shares lost 25.65% of their value over the last 52 weeks. On November 28, 2025, Pro-Dex, Inc. (NASDAQ:PDEX) stock closed at $36.44 per share, with a market capitalization of $119.523 million.
Long Cast Advisers stated the following regarding Pro-Dex, Inc. (NASDAQ:PDEX) in its third quarter 2025 investor letter:
“Pro-Dex, Inc. (NASDAQ:PDEX) issued a mid-September press release after a significant and unexplained decline in the stock that basically said: “Please be aware we aren’t the blockchain platform that trades under the same ticker in the crypto markets.” Then it added a new risk disclosure in its 10Q “AI-errors could be bad for the stock” and indicated that a litigation-focused law firm issued an AI-generated press release based on two year old news and stale financial data to solicit shareholders for a potential class action.
